Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
NeuroOne Medical Technologies Corporation (NMTC) had Return on Equity of -1498.53% for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
$3.45M |
|
$-12.32M |
|
$2.37M |
|
$1.08M |
|
$15.34M |
|
$-11.89M |
|
$-0.43M |
|
$-12.32M |
|
$-12.32M |
|
$-12.32M |
|
$-12.32M |
|
$-12.32M |
|
$-12.32M |
|
$-11.89M |
|
$-11.54M |
|
26.76M |
|
26.76M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$4.63M |
|
$0.42M |
|
$0.74M |
|
$5.37M |
|
$2.21M |
|
-- |
|
$2.33M |
|
$4.55M |
|
$0.82M |
|
$0.75M |
|
$0.82M |
|
30.82M |
|
| Cash Flow Statement Financials | |
$-11.01M |
|
$-0.12M |
|
$7.27M |
|
$5.32M |
|
$1.46M |
|
$-3.86M |
|
$1.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
31.27% |
|
-344.26% |
|
-344.26% |
|
-334.18% |
|
-356.74% |
|
-356.74% |
|
$-11.13M |
|
-- |
|
-- |
|
-- |
|
0.64 |
|
0.90 |
|
19.55 |
|
18.67 |
|
|
Return on Equity |
-1498.53% |
-1632.08% |
|
-229.39% |
|
-1498.53% |
|
$0.03 |
|
$-0.42 |
|
$-0.41 |
|